Gaucher disease: genes and variants
Explore variant evidence for Gaucher disease across 1 analyzed protein (GBA1). Linked ClinVar records include 132 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 38 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Gaucher disease
GBA1: Lysosomal acid glucosylceramidase
It degrades glucosylceramide within lysosomes and is essential for normal sphingolipid turnover. Biallelic pathogenic variants cause Gaucher disease, while heterozygous pathogenic variants are among the strongest genetic risk factors for Parkinson disease.
132 ClinVar pathogenic / likely pathogenic and 62 uncertain variants in GBA1 have source records linked to Gaucher disease. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Gaucher disease
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| GBA1 R87Q | 87 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R159Q | 159 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R159W | 159 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R170L | 170 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R170C | 170 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R209C | 209 | Pathogenic / likely pathogenic (★★) | |
| GBA1 P221T | 221 | Pathogenic / likely pathogenic (★★) | |
| GBA1 G234E | 234 | Pathogenic / likely pathogenic (★★) | |
| GBA1 F255Y | 255 | Pathogenic / likely pathogenic (★★) | |
| GBA1 I299T | 299 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R392W | 392 | Pathogenic / likely pathogenic (★★) | |
| GBA1 W417G | 417 | Pathogenic / likely pathogenic (★★) | |
| GBA1 D419N | 419 | Pathogenic / likely pathogenic (★★) | |
| GBA1 D419A | 419 | Pathogenic / likely pathogenic (★★) | |
| GBA1 N501K | 501 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R502C | 502 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R502H | 502 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R87W | 87 | Pathogenic / likely pathogenic (★★) | |
| GBA1 N227I | 227 | Pathogenic / likely pathogenic (★★) | |
| GBA1 D419H | 419 | Pathogenic / likely pathogenic (★★) | |
| GBA1 D448H | 448 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R83C | 83 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R83L | 83 | Pathogenic / likely pathogenic (★★) | |
| GBA1 G85E | 85 | Pathogenic / likely pathogenic (★★) | |
| GBA1 S164R | 164 | Pathogenic / likely pathogenic (★★) | |
| GBA1 N227S | 227 | Pathogenic / likely pathogenic (★★) | |
| GBA1 N227K | 227 | Pathogenic / likely pathogenic (★★) | |
| GBA1 K237E | 237 | Pathogenic / likely pathogenic (★★) | |
| GBA1 F252I | 252 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R296Q | 296 | Pathogenic / likely pathogenic (★★) | |
| GBA1 F298L | 298 | Pathogenic / likely pathogenic (★★) | |
| GBA1 H350R | 350 | Pathogenic / likely pathogenic (★★) | |
| GBA1 Y352H | 352 | Pathogenic / likely pathogenic (★★) | |
| GBA1 L363P | 363 | Pathogenic / likely pathogenic (★★) | |
| GBA1 V391L | 391 | Pathogenic / likely pathogenic (★★) | |
| GBA1 S395F | 395 | Pathogenic / likely pathogenic (★★) | |
| GBA1 V414L | 414 | Pathogenic / likely pathogenic (★★) | |
| GBA1 G416S | 416 | Pathogenic / likely pathogenic (★★) | |
| GBA1 L424P | 424 | Pathogenic / likely pathogenic (★★) | |
| GBA1 P430L | 430 | Pathogenic / likely pathogenic (★★) | |
| GBA1 V433L | 433 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R434C | 434 | Pathogenic / likely pathogenic (★★) | |
| GBA1 D438N | 438 | Pathogenic / likely pathogenic (★★) | |
| GBA1 L483R | 483 | Pathogenic / likely pathogenic (★★) | |
| GBA1 M162K | 162 | Pathogenic / likely pathogenic (★★) | |
| GBA1 T173I | 173 | Pathogenic / likely pathogenic (★★) | |
| GBA1 T362I | 362 | Pathogenic / likely pathogenic (★★) | |
| GBA1 E388K | 388 | Pathogenic / likely pathogenic (★★) | |
| GBA1 S403T | 403 | Pathogenic / likely pathogenic (★★) | |
| GBA1 F450I | 450 | Pathogenic / likely pathogenic (★★) | |
| GBA1 S77R | 77 | Pathogenic / likely pathogenic (★★) | |
| GBA1 T82I | 82 | Pathogenic / likely pathogenic (★★) | |
| GBA1 V230G | 230 | Pathogenic / likely pathogenic (★★) | |
| GBA1 S235P | 235 | Pathogenic / likely pathogenic (★★) | |
| GBA1 G241R | 241 | Pathogenic / likely pathogenic (★★) | |
| GBA1 Y259C | 259 | Pathogenic / likely pathogenic (★★) | |
| GBA1 Y283H | 283 | Pathogenic / likely pathogenic (★★) | |
| GBA1 G364R | 364 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R398Q | 398 | Pathogenic / likely pathogenic (★★) | |
| GBA1 R535C | 535 | Pathogenic / likely pathogenic (★★) |
Showing 60 of 132.
Uncertain variants prioritized for review in Gaucher disease
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| GBA1 D354H | 354 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; D354N at the same position is pathogenic; REVEL 0.972 | |
| GBA1 P305A | 305 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; P305L at the same position is pathogenic; REVEL 0.948 | |
| GBA1 M162T | 162 | Conflicting reports (★) | +6: 7 other pathogenic changes within 3 positions; M162K at the same position is pathogenic; REVEL 0.922 | |
| GBA1 G416R | 416 | Conflicting reports (★) | +6: 8 other pathogenic changes within 3 positions; G416S at the same position is pathogenic; REVEL 0.956 | |
| GBA1 R170H | 170 | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; R170L at the same position is pathogenic; REVEL 0.852 | |
| GBA1 N435K | 435 | Uncertain | +6: 5 other pathogenic changes within 3 positions; N435T at the same position is pathogenic; REVEL 0.862 |
Same protein, different disease
- Parkinson disease also has ClinVar records linked to GBA1 variants; they fall in the same places as the Gaucher disease variants (8 pathogenic / likely pathogenic).
- Lewy body dementia also has ClinVar records linked to GBA1 variants; they fall in the same places as the Gaucher disease variants (6 pathogenic / likely pathogenic).
- Gaucher disease perinatal lethal also has ClinVar records linked to GBA1 variants; they fall in the same places as the Gaucher disease variants (5 pathogenic / likely pathogenic).
Diseases related to Gaucher disease
- Parkinson disease, also linked to GBA1
- Lewy body dementia, also linked to GBA1
- Gaucher disease perinatal lethal, also linked to GBA1
- Gaucher disease - ophthalmoplegia - cardiovascular calcification, also linked to GBA1
Frequently asked questions
Which genes have records linked to Gaucher disease?
This view contains 1 analyzed proteins: GBA1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 132 pathogenic or likely pathogenic variants, 24 variants of uncertain significance and 38 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 6 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 222 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center